IONS IONIS PHARMACEUTICALS INC
Nasdaq · SEC CIK 874015 · EDGAR
- Bought, last 12 months
- $1.06M 1 purchases by 1 insiders
- Sold, last 12 months
- $155.27M 88 sales by 19 insiders
- Filings on record
- 492 since 2021-07-06, latest 2026-09-02 20:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Monia Brett P | CEO, Dir | — | $30.35M |
| HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| BENNETT C FRANK | EVP, CSO | — | $16.71M |
| Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| Swayze Eric | EVP Research | — | $7.51M |
| LOSCALZO JOSEPH | Dir | — | $7.09M |
| KLEIN JOSEPH III | Dir | — | $6.00M |
| WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 537
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-01-20 | 2026-01-15 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +2,850 | 5,921 | +93% | $0 |
| D | 2026-01-20 | 2026-01-15 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +21.7K | 73.2K | +42% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $75.59 | -9,302 | 63.9K | -13% | -$703.1K |
| D | 2026-01-20 | 2026-01-15 | IONS | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | M - OptEx | $0.00 | +7,013 | 18.2K | +63% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | S - Sale+OE | $75.96 | -1,823 | 16.4K | -10% | -$138.5K |
| D | 2026-01-20 | 2026-01-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +21.4K | 51.8K | +70% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $75.34 | -9,884 | 41.9K | -19% | -$744.7K |
| DI | 2026-01-20 | 2026-01-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +111 | 367 | +43% | $0 |
| DI | 2026-01-20 | 2026-01-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $75.97 | -49 | 318 | -13% | -$3,723 |
| D | 2026-01-20 | 2026-01-16 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $75.15 | -8,977 | 94.8K | -9% | -$674.6K |
| D | 2026-01-20 | 2026-01-15 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +21.1K | 103.7K | +25% | $0 |
| D | 2026-01-20 | 2026-01-15 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $0.00 | +21.5K | 75.4K | +40% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $75.84 | -9,191 | 66.2K | -12% | -$697.0K |
| D | 2026-01-20 | 2026-01-15 | IONS | YANG MICHAEL J. | Dir | M - OptEx | $0.00 | +1,930 | 7,940 | +32% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $75.95 | -8,353 | 26.5K | -24% | -$634.4K |
| D | 2026-01-20 | 2026-01-15 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $0.00 | +17.4K | 34.9K | +99% | $0 |
| D | 2026-01-20 | 2026-01-15 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | +20.1K | 68.9K | +41% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $75.11 | -8,480 | 60.4K | -12% | -$636.9K |
| D | 2026-01-20 | 2026-01-16 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $75.22 | -12.9K | 126.3K | -9% | -$972.0K |
| D | 2026-01-20 | 2026-01-15 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +28.7K | 139.2K | +26% | $0 |
| D | 2026-01-20 | 2026-01-15 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $0.00 | +89.1K | 268.7K | +50% | $0 |
| D | 2026-01-20 | 2026-01-16 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $74.82 | -44.0K | 224.7K | -16% | -$3.29M |
| DM | 2026-01-09 | 2026-01-07 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $51.25 | +44.2K | 21.0K | New | +$2.27M |
| DM | 2026-01-09 | 2026-01-07 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $85.08 | -44.2K | 17.5K | -72% | -$3.76M |
| DM | 2026-01-06 | 2026-01-02 | IONS | Swayze Eric | EVP Research | M - OptEx | $60.89 | +23.5K | 48.8K | +93% | +$1.43M |
| DM | 2026-01-06 | 2026-01-02 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $79.12 | -23.5K | 30.5K | -44% | -$1.86M |
| MI | 2025-12-03 | 2025-12-01 | IONS | WENDER JOSEPH H | Dir | S - Sale | $80.82 | -28.0K | 36.0K | -44% | -$2.26M |
| DMI | 2025-11-28 | 2025-11-25 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $80.00 | -12.0K | 0 | -100% | -$960.0K |
| DMI | 2025-11-28 | 2025-11-25 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | +12.0K | 4,000 | New | $0 |
| D | 2025-11-28 | 2025-11-25 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $80.91 | -16.8K | 17.5K | -49% | -$1.36M |
| D | 2025-11-28 | 2025-11-25 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $53.77 | +16.8K | 34.3K | +96% | +$902.1K |
| DM | 2025-11-20 | 2025-11-19 | IONS | HERMAN JOAN E | Dir | S - Sale+OE | $72.13 | -44.0K | 46.1K | -49% | -$3.17M |
| DM | 2025-11-20 | 2025-11-19 | IONS | HERMAN JOAN E | Dir | M - OptEx | $57.40 | +44.0K | 58.1K | +312% | +$2.53M |
| D | 2025-11-20 | 2025-11-18 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $24.42 | +16.0K | 16.0K | New | +$390.7K |
| DM | 2025-11-07 | 2025-11-05+ | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $59.05 | +34.6K | 60.5K | +134% | +$2.05M |
| DM | 2025-11-07 | 2025-11-05+ | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $75.69 | -34.6K | 59.7K | -37% | -$2.62M |
| 2025-11-07 | 2025-11-06 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale | $76.17 | -8,000 | 48.8K | -14% | -$609.4K | |
| DMA | 2025-11-07 | 2025-11-03 | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $58.68 | +1,680 | 60.6K | +3% | +$98.6K |
| DMA | 2025-11-07 | 2025-11-03 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $75.05 | -1,680 | 59.7K | -3% | -$126.1K |
| D | 2025-11-03 | 2025-10-31 | IONS | LOSCALZO JOSEPH | Dir | S - Sale+OE | $75.10 | -16.0K | 36.3K | -31% | -$1.20M |
| D | 2025-11-03 | 2025-10-31 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $52.22 | +16.0K | 52.3K | +44% | +$835.5K |
| DM | 2025-11-03 | 2025-10-31+ | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $58.84 | +70.9K | 114.2K | +164% | +$4.17M |
| DM | 2025-11-03 | 2025-10-31+ | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $75.11 | -90.9K | 79.7K | -53% | -$6.83M |
| MI | 2025-11-03 | 2025-10-30+ | IONS | WENDER JOSEPH H | Dir | S - Sale | $74.02 | -28.0K | 75.2K | -27% | -$2.07M |
| DI | 2025-10-16 | 2025-10-15 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 309 | +68% | $0 |
| DI | 2025-10-16 | 2025-10-16 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $73.62 | -53 | 256 | -17% | -$3,902 |
| DM | 2025-10-16 | 2025-10-15 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $33.00 | +8,820 | 21.9K | +67% | +$291.1K |
| DM | 2025-10-16 | 2025-10-15+ | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $73.06 | -7,263 | 17.5K | -29% | -$530.6K |
| DM | 2025-10-16 | 2025-10-14+ | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $53.77 | +23.9K | 68.3K | +54% | +$1.29M |
| DM | 2025-10-16 | 2025-10-14+ | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $72.13 | -23.9K | 56.8K | -30% | -$1.72M |
| 2025-10-16 | 2025-10-15 | IONS | PARSHALL B LYNNE | Dir | S - Sale | $71.74 | -5,000 | 61.3K | -8% | -$358.7K | |
| 2025-10-08 | 2025-10-06 | IONS | Swayze Eric | EVP Research | S - Sale | $69.02 | -6,849 | 30.5K | -18% | -$472.7K | |
| 2025-10-08 | 2025-10-06 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale | $69.37 | -1,625 | 30.3K | -5% | -$112.7K | |
| DM | 2025-10-08 | 2025-10-06 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $69.74 | -13.4K | 53.9K | -20% | -$937.4K |
| D | 2025-10-08 | 2025-10-06 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $52.87 | +10.2K | 67.3K | +18% | +$539.3K |
| 2025-10-08 | 2025-10-06 | IONS | Monia Brett P | CEO, Dir | S - Sale | $69.26 | -437 | 179.6K | -0.2% | -$30.3K | |
| I | 2025-10-02 | 2025-10-01 | IONS | WENDER JOSEPH H | Dir | S - Sale | $65.50 | -16.8K | 92.0K | -15% | -$1.10M |
| DM | 2025-10-02 | 2025-10-01+ | IONS | Swayze Eric | EVP Research | S - Sale+OE | $66.16 | -27.1K | 37.3K | -42% | -$1.79M |
| DM | 2025-10-02 | 2025-10-01+ | IONS | Swayze Eric | EVP Research | M - OptEx | $53.77 | +27.1K | 51.4K | +111% | +$1.46M |
| DM | 2025-10-02 | 2025-10-02 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $67.69 | -64.7K | 57.1K | -53% | -$4.38M |
| DM | 2025-10-02 | 2025-10-02 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $58.97 | +64.7K | 91.6K | +240% | +$3.81M |
| D | 2025-10-02 | 2025-10-02 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $68.01 | -15.0K | 31.9K | -32% | -$1.02M |
| D | 2025-10-02 | 2025-10-02 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $31.80 | +15.0K | 46.9K | +47% | +$477.0K |
| D | 2025-10-01 | 2025-09-30 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $53.77 | +49.8K | 160.3K | +45% | +$2.68M |
| D | 2025-10-01 | 2025-09-30 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $65.26 | -49.8K | 110.5K | -31% | -$3.25M |
| D | 2025-10-01 | 2025-09-30 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $65.24 | -57.9K | 79.7K | -42% | -$3.78M |
| D | 2025-10-01 | 2025-09-30 | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $53.77 | +57.9K | 137.6K | +73% | +$3.11M |
| DM | 2025-10-01 | 2025-09-29+ | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $64.62 | -25.3K | 57.1K | -31% | -$1.63M |
| DM | 2025-10-01 | 2025-09-29+ | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $56.78 | +25.3K | 67.6K | +60% | +$1.44M |
| D | 2025-09-16 | 2025-09-12 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $64.58 | -1,700 | 57.1K | -3% | -$109.8K |
| D | 2025-09-16 | 2025-09-12 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $56.78 | +1,700 | 58.8K | +3% | +$96.5K |
| D | 2025-09-11 | 2025-09-09 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $31.80 | +11.9K | 43.9K | +37% | +$380.0K |
| D | 2025-09-11 | 2025-09-09 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $62.16 | -11.9K | 31.9K | -27% | -$742.8K |
| DM | 2025-09-11 | 2025-09-09 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $60.69 | +21.0K | 58.1K | +57% | +$1.27M |
| DM | 2025-09-11 | 2025-09-09 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $64.56 | -21.0K | 57.1K | -27% | -$1.36M |
| 2025-09-09 | 2025-09-05 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale | $59.60 | -6,000 | 82.7K | -7% | -$357.6K | |
| D | 2025-09-09 | 2025-09-05 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $62.00 | -250 | 31.9K | -0.8% | -$15.5K |
| D | 2025-09-09 | 2025-09-05 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $31.80 | +250 | 32.2K | +0.8% | +$7,950 |
| MI | 2025-09-04 | 2025-09-02+ | IONS | WENDER JOSEPH H | Dir | S - Sale | $57.58 | -28.0K | 120.0K | -19% | -$1.61M |
| M | 2025-09-04 | 2025-09-02 | IONS | PARSHALL B LYNNE | Dir | S - Sale | $50.91 | -20.0K | 75.6K | -21% | -$1.02M |
| 2025-09-04 | 2025-09-02 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $50.37 | -10.0K | 79.7K | -11% | -$503.7K | |
| MI | 2025-09-04 | 2025-09-02+ | IONS | WENDER JOSEPH H | Dir | S - Sale | $57.58 | -28.0K | 120.0K | -19% | -$1.61M |
| D | 2025-09-04 | 2025-09-03 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | S - Sale+OE | $61.02 | -3,162 | 15.0K | -17% | -$192.9K |
| DM | 2025-09-04 | 2025-09-03 | IONS | Devers Shannon L. | EVP, Chief Human Resources Ofc | M - OptEx | $36.12 | +3,162 | 18.2K | +21% | +$114.2K |
| DMI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | +28.0K | 16.0K | New | $0 |
| DI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $60.00 | -28.0K | 0 | -100% | -$1.68M |
| M | 2025-09-04 | 2025-09-02 | IONS | Swayze Eric | EVP Research | S - Sale | $49.67 | -11.1K | 38.4K | -22% | -$552.9K |
| DM | 2025-09-04 | 2025-09-02+ | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $45.10 | +89.9K | 57.1K | New | +$4.05M |
| DM | 2025-09-04 | 2025-09-02+ | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $60.03 | -89.9K | 7,330 | -92% | -$5.40M |
| D | 2025-09-04 | 2025-09-03 | IONS | LOSCALZO JOSEPH | Dir | S - Sale+OE | $60.15 | -16.0K | 36.3K | -31% | -$962.4K |
| D | 2025-09-04 | 2025-09-03 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $24.42 | +16.0K | 52.3K | +44% | +$390.7K |
| DMI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $0.00 | +28.0K | 16.0K | New | $0 |
| DI | 2025-09-04 | 2025-09-03 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $60.00 | -28.0K | 0 | -100% | -$1.68M |
| DM | 2025-09-04 | 2025-09-03 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $60.81 | -19.7K | 51.5K | -28% | -$1.20M |
| D | 2025-09-04 | 2025-09-03 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $53.77 | +19.7K | 71.2K | +38% | +$1.06M |
| DM | 2025-09-04 | 2025-09-02+ | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $59.14 | -38.9K | 101.6K | -28% | -$2.30M |
| DM | 2025-09-04 | 2025-09-03 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $55.44 | +33.9K | 88.7K | +62% | +$1.88M |
| DM | 2025-09-04 | 2025-09-03 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $59.34 | -32.8K | 31.9K | -51% | -$1.95M |
| DM | 2025-09-04 | 2025-09-03 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $31.80 | +32.8K | 34.7K | +1,703% | +$1.04M |
| DM | 2025-09-04 | 2025-09-03 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $60.32 | -203.8K | 266.3K | -43% | -$12.29M |
Purchase Sale Sale after option exercise All abbreviations